ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026
Brain health care accelerator: A primary care-centered model for scaling dementia diagnosis and care.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
Plasma biomarkers and disease-modifying therapies for early Alzheimer's disease have created an urgent need for scalable care models. In this Perspectives, we describe how a health system is adapting dementia care delivery through a primary care provider (PCP)-centered initiative designed to improve diagnostic readiness and care capacity. The program integrates (1) blood-based biomarker testing into clinical workflows, (2) a Cognitive Assessment Visit (CAV) supported by Electronic Health Record-embedded decision tools, and (3) memory care co-management. Early implementation demonstrates that PCPs can be empowered to diagnose and manage cognitive impairment through structured workflows, targeted training, and specialist collaboration. In the first 26 weeks, 1,331 plasma p-tau217 tests were ordered by 104 clinicians, including 58 PCPs; 59 CAVs were completed by nine PCPs; and more than 330 asynchronous e-consults expanded specialist access. These results highlight the feasibility and challenges of integrating biomarker-informed dementia care within primary care workflows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.